Facial AgingNCT07285577
Facial Muscle Exercises vs Fractional Microneedling Radiofrequency for Facial Rejuvenation
A study testing Facial Muscle Exercise Program and Vivace® Fractional Microneedling Radiofrequency in people with Facial Aging, run by Kasr El Aini Hospital at 1 site in Egypt.
Trial summary
This randomized controlled trial compared the effectiveness and safety of fractional microneedling radiofrequency (FMR) and facial muscle exercises (FME) for facial rejuvenation in females with mild to moderate facial aging. Read more about this study
- Who is it for?
- Ages 30 years and older, women only
- Conditions the study is for
- Facial Aging
- What is being tested?
- Facial Muscle Exercise Program and Vivace® Fractional Microneedling Radiofrequency
- Type of treatment
- Medical device, Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 40 participants
- Where
- 1 siteEgypt
- Study dates
- 1 Apr 2023to 10 Jun 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 30 years and older
- Women only
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Female participants aged ≥30 years
- Mild to moderate facial aging (defined as grade 2-3 on Modified Quantitative Comprehensive Grading Scale of Aging and grade 2-4 on Wrinkle Severity Rating Scale)
- Literate and able to follow instructions
- Familiar with using online applications (e.g., Zoom) and have reliable internet access
- Provided written informed consent for participation and photography
Who cannot join
- Age <30 years
- Severe facial aging (grade 4 on MQCGS and grade 5 on WSRS)
- Current smoker
- History of previous facelift surgery or thread lifting Botulinum toxin or filler injection within the past 12 months
- Mesotherapy or topical rejuvenating therapy within the past 3 months
- Body dysmorphic disorder
Show all 10Show fewer
- Medical history of autoimmune diseases, diabetes, or systemic conditions affecting healing
- Pregnancy or lactation
- Illiteracy or inability to follow instructions
- Lack of internet access or inability to use online applications
Trial locations and contacts
1 site in 1 country.
Egypt1 site
Kasr El Aini Hospital, Cairo, English (English)
Cairo, Cairo Governorate, 11511
About this study
Official title: Fractional Microneedling Radiofrequency Versus Facial Muscle Exercises for Facial Rejuvenation: A Randomized Controlled Trial
This randomized controlled trial compared the effectiveness and safety of fractional microneedling radiofrequency (FMR) and facial muscle exercises (FME) for facial rejuvenation in females with mild to moderate facial aging. Forty participants aged 32-65 were randomized to either an 8-week FME program or three FMR sessions at 4-week intervals. Outcomes included modified quantitative comprehensive grading scale of aging (MQCGS), wrinkle severity rating scale (WSRS), physician global aesthetic improvement score (PGAI), subject global aesthetic improvement score (SGAIS), and patient satisfaction. Primary endpoints were treatment success (≥25% improvement in PGAI) and patient satisfaction at Day 90. Secondary outcomes assessed changes in aging scores, wrinkle severity, and improvement type (lifting versus texture effects). Ethics approval was obtained from the Research Ethics Committee, Faculty of Medicine, Cairo University.
Read the detailed description
Facial aging involves changes in skin texture, loss of volume, and tissue descent. Fractional microneedling radiofrequency (FMR) delivers controlled thermal injury via microneedles to stimulate collagen and elastin, with proposed benefits for skin texture and firmness. Facial muscle exercises (FME), or face yoga, aim to strengthen facial muscles, enhance tone, and lift sagging tissues. This single-center, outpatient, randomized, active-controlled, parallel-group trial enrolled 40 female participants aged ≥30 years with mild to moderate facial aging. Group A received an 8-week FME program (weekly online sessions plus daily home exercises). Group B underwent three FMR sessions using Vivace® device (non-insulated microneedles, 3.5 mm depth, 8 W, 600 ms pulse) at 4-week intervals. Primary outcomes were treatment success (≥25% improvement in PGAI) and patient satisfaction at Day 90. Secondary outcomes included MQCGS, WSRS, SGAIS, and improvement type (lifting versus texture). The study aimed to compare the two interventions across these outcome measures. Ethics approval was granted by the Research Ethics Committee, Faculty of Medicine, Cairo University; informed consent was obtained from all participants.
- Conditions
- Facial Aging
- Being tested
- Facial Muscle Exercise Program, Vivace® Fractional Microneedling Radiofrequency
- Keywords
- Facial rejuvenation, Fractional microneedling radiofrequency, Face yoga, Facial muscle exercises, Non-surgical facelift, Radiofrequency, Wrinkle reduction, Skin texture improvement
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Facial Muscle Exercise ProgramBehavioural
Eight-week course with weekly online sessions and daily home exercises demonstrated via video. Exercises aimed to improve facial muscle tone and lifting effect.
Vivace® Fractional Microneedling RadiofrequencyDevice
Three sessions spaced 4 weeks apart; non-insulated microneedles; depth 3.5 mm; power 8 W; pulse 800 ms; pre-treatment topical anesthesia; post-treatment care with antibiotics and moisturizers.
| Study group | Role | What they receive |
|---|---|---|
| Facial Muscle Exercises (FME) | Experimental | Participants received an 8-week facial muscle exercise program consisting of weekly online sessions led by the investigator and daily home exercises. Exercises targeted nasolabial folds and jawline using techniques such as "Big O," "Nasolabial Lift Up," "Nasolabial Smoother," "Rolly Polly," "Swan Neck," and "Pulled Tongue," following the Face Yoga method. Receives: Behavioral: Facial Muscle Exercise Program |
| Fractional Microneedling Radiofrequency (FMR) | Experimental | Participants underwent three sessions of fractional microneedling radiofrequency using the Vivace® device at 4-week intervals. Non-insulated microneedles were used with parameters: depth 3.5 mm, power 8 W, pulse duration 800 ms. Local anesthetic cream applied before each session; topical antibiotics and moisturizers used post-procedure. Receives: Device: Vivace® Fractional Microneedling Radiofrequency |
What is being measured
The primary outcome is the main question the study is designed to answer.
Treatment Success (≥25% improvement in Physician Global Aesthetic Improvement Score)
Proportion of participants achieving ≥25% improvement in PGAI compared to baseline.
Measured: Day 90 (End of Study)
Patient Satisfaction
Measured on a 3-point scale (0 = not satisfied, 1 = moderately satisfied, 2 = very satisfied).
Measured: Day 90 (End of Study)
Secondary outcomes (4)
Modified Quantitative Comprehensive Grading Scale of Aging (MQCGS)
Change from baseline in Modified Quantitative Comprehensive Grading Scale of Aging (MQCGS) score. Scale range: 0-33 points, with higher scores indicating more severe facial aging (worse outcome).
Measured: Baseline, Day 30, Day 60, Day 90
Wrinkle Severity Rating Scale (WSRS)
Change from baseline in Wrinkle Severity Rating Scale (WSRS) score for nasolabial folds. Scale range: 1-5, with higher scores indicating more severe wrinkles (worse outcome).
Measured: Baseline, Day 30, Day 60, Day 90
Subject Global Aesthetic Improvement Score (SGAIS)
Patient-reported improvement compared to baseline using Subject Global Aesthetic Improvement Score (SGAIS). Scale range: -1 to +3, with higher scores indicating greater improvement (better outcome). (-1 = worse, 0 = no change, +1 = improved, +2 = much improved, +3 = very much improved)
Measured: Day 30, Day 60, Day 90
Improvement Type
Classification of improvement as "lifting," "texture," or "both" based on blinded dermatologist review.
Measured: Day 90
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Dec 2025
- Study start1 Apr 2023
- Primary completion1 Feb 2024
- Study completion10 Jun 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Facial AgingStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 40 participants (actual)
Sponsor and investigators
- Lead sponsor
- Kasr El Aini Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, heba ahmed abdelgayed ibrahim, Kasr El Aini Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07285577
- Sponsor's protocol ID
- MS-63-2022
- Status last verified
- Dec 2025
- First submitted
- 10 Dec 2025
- Last updated
- 16 Dec 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual participant data (IPD) will not be shared because this is a single-center study with a small sample size, and de-identification cannot be fully guaranteed. Aggregate results, including summary statistics and outcome analyses, will be made available through publication
Study at a glance
From the registry record, last updated by the sponsor on 16 Dec 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Fractional Microneedling Radiofrequency Versus Facial Muscle Exercises for Facial Rejuvenation: A Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT07285577
- Acronym / sponsor ID
- MS-63-2022
- Conditions
- Facial Aging
- Keywords
- Facial rejuvenation, Fractional microneedling radiofrequency, Face yoga, Facial muscle exercises, Non-surgical facelift, Radiofrequency, Wrinkle reduction, Skin texture improvement
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 40 participants (actual)
- Lead sponsor
- Kasr El Aini HospitalUniversity, hospital or other
- Study start
- 1 Apr 2023 (actual)
- Primary completion
- 1 Feb 2024 (actual)
- Study completion
- 10 Jun 2024 (actual)
- First posted
- 16 Dec 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This randomized controlled trial compared the effectiveness and safety of fractional microneedling radiofrequency (FMR) and facial muscle exercises (FME) for facial rejuvenation in females with mild to moderate facial aging. Forty participants aged 32-65 were randomized to either an 8-week FME program or three FMR sessions at 4-week intervals. Outcomes included modified quantitative comprehensive grading scale of aging (MQCGS), wrinkle severity rating scale (WSRS), physician global aesthetic improvement score (PGAI), subject global aesthetic improvement score (SGAIS), and patient satisfaction. Primary endpoints were treatment success (≥25% improvement in PGAI) and patient satisfaction at Day 90. Secondary outcomes assessed changes in aging scores, wrinkle severity, and improvement type (lifting versus texture effects). Ethics approval was obtained from the Research Ethics Committee, Faculty of Medicine, Cairo University.
Detailed description
Facial aging involves changes in skin texture, loss of volume, and tissue descent. Fractional microneedling radiofrequency (FMR) delivers controlled thermal injury via microneedles to stimulate collagen and elastin, with proposed benefits for skin texture and firmness. Facial muscle exercises (FME), or face yoga, aim to strengthen facial muscles, enhance tone, and lift sagging tissues. This single-center, outpatient, randomized, active-controlled, parallel-group trial enrolled 40 female participants aged ≥30 years with mild to moderate facial aging. Group A received an 8-week FME program (weekly online sessions plus daily home exercises). Group B underwent three FMR sessions using Vivace® device (non-insulated microneedles, 3.5 mm depth, 8 W, 600 ms pulse) at 4-week intervals. Primary outcomes were treatment success (≥25% improvement in PGAI) and patient satisfaction at Day 90. Secondary outcomes included MQCGS, WSRS, SGAIS, and improvement type (lifting versus texture). The study aimed to compare the two interventions across these outcome measures. Ethics approval was granted by the Research Ethics Committee, Faculty of Medicine, Cairo University; informed consent was obtained from all participants.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Facial Muscle Exercises (FME) | Experimental | Behavioral: Facial Muscle Exercise ProgramParticipants received an 8-week facial muscle exercise program consisting of weekly online sessions led by the investigator and daily home exercises. Exercises targeted nasolabial folds and jawline using techniques such as "Big O," "Nasolabial Lift Up," "Nasolabial Smoother," "Rolly Polly," "Swan Neck," and "Pulled Tongue," following the Face Yoga method. |
| Fractional Microneedling Radiofrequency (FMR) | Experimental | Device: Vivace® Fractional Microneedling RadiofrequencyParticipants underwent three sessions of fractional microneedling radiofrequency using the Vivace® device at 4-week intervals. Non-insulated microneedles were used with parameters: depth 3.5 mm, power 8 W, pulse duration 800 ms. Local anesthetic cream applied before each session; topical antibiotics and moisturizers used post-procedure. |
Who may qualify
- Ages
- 30 years and older
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Female participants aged ≥30 years
- Mild to moderate facial aging (defined as grade 2-3 on Modified Quantitative Comprehensive Grading Scale of Aging and grade 2-4 on Wrinkle Severity Rating Scale)
- Literate and able to follow instructions
- Familiar with using online applications (e.g., Zoom) and have reliable internet access
- Provided written informed consent for participation and photography
Key exclusion criteria (10 listed)
- Age <30 years
- Severe facial aging (grade 4 on MQCGS and grade 5 on WSRS)
- Current smoker
- History of previous facelift surgery or thread lifting Botulinum toxin or filler injection within the past 12 months
- Mesotherapy or topical rejuvenating therapy within the past 3 months
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Facial Muscle Exercise ProgramEight-week course with weekly online sessions and daily home exercises demonstrated via video. Exercises aimed to improve facial muscle tone and lifting effect. | Behavioural | Facial Muscle Exercises (FME) |
| Vivace® Fractional Microneedling RadiofrequencyThree sessions spaced 4 weeks apart; non-insulated microneedles; depth 3.5 mm; power 8 W; pulse 800 ms; pre-treatment topical anesthesia; post-treatment care with antibiotics and moisturizers. | Device | Fractional Microneedling Radiofrequency (FMR) |
Primary outcome
Treatment Success (≥25% improvement in Physician Global Aesthetic Improvement Score)
Time frame: Day 90 (End of Study)
Proportion of participants achieving ≥25% improvement in PGAI compared to baseline.
Patient Satisfaction
Time frame: Day 90 (End of Study)
Measured on a 3-point scale (0 = not satisfied, 1 = moderately satisfied, 2 = very satisfied).
4 secondary outcomes
Modified Quantitative Comprehensive Grading Scale of Aging (MQCGS)
Time frame: Baseline, Day 30, Day 60, Day 90
Wrinkle Severity Rating Scale (WSRS)
Time frame: Baseline, Day 30, Day 60, Day 90
Subject Global Aesthetic Improvement Score (SGAIS)
Time frame: Day 30, Day 60, Day 90
Improvement Type
Time frame: Day 90
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Dec 2025.
- Individual participant dataSharing planned: No. Individual participant data (IPD) will not be shared because this is a single-center study with a small sample size, and de-identification cannot be fully guaranteed. Aggregate results, including summary statistics and outcome analyses, will be made available through publication
Related trials for Facial Aging
Not yet recruiting
Evaluation of MD60002 Device for Facial Skin Aging
Facial Wrinkles, Skin Aging
Not yet recruiting
Antioxidant Nutrition and Facial Exercise for Skin Aging
Facial Skin Aging and Wrinkle Severity
RecruitingObservational study
Artificial Intelligence-Based Health Assessment From Face Photographs - Healthy Volunteer Study
Aging, Facial Aging
Not yet recruitingObservational study
Comparing Facial Aging Between Identical Twins With 3D Imaging
Facial Skin Aging, Facial Volume Loss
Not yet recruitingPhase 3
Objective Evaluation of Intradermal MSC-Derived Exosome Therapy on Facial Skin Quality
Skin Aging, Facial Aging
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Facial Muscle Exercise Program and Vivace® Fractional Microneedling Radiofrequency in people with Facial Aging, run by Kasr El Aini Hospital at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 16 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Treatment Success (≥25% improvement in Physician Global Aesthetic Improvement Score) (time frame: Day 90 (End of Study)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Dec 2025; AzTrials last refreshed its copy on 8 Nov 2026.